"On Aug. 6, Alteryx reported second-quarter earnings. The aftermath was a disaster for shareholders, but let’s have a look at the numbers before getting into that.There were some bright spots in the company’s Q2. Revenue of $96.2 million was up 17% year-over-year, and beat Wall Street’s estimates of $94.11 million. Adjusted earnings per share of 2 cents also handily beat expectations. It was up from 1 cent per share a year ago, and far better than the 14 cents per share loss that Wall Street had predicted.
The company’s customer count was up 27% YoY, with 271 new customers added in the second quarter. Annual recurring revenue (ARR) grew 40% to $430 million.
The company also expanded its product offerings:....
The operating loss of $17.79 million for the quarter widened by 114.6% compared to Q2 2019. The net loss of $35.29 million was up a whopping 996% YoY. Guidance was also weaker than expected, due to customers cutting costs and changing their spending patterns during the pandemic. The company released Q3 guidance for revenue of between $111 million and $115 million — up 7% to 10%.
Yes, the coronavirus pandemic has thrown a wrench in the works for Alteryx. With companies cutting costs where they can, spending on data analytics is vulnerable to being pushed to the side. However, this is going to be a temporary setback. That makes the cratering of AYX stock in August — a level it has yet to recover from – a buying opportunity.
https://investorplace.com/2020/09/...op-ayx-stock-offers-opportunity/ |
